Skip to main content

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results and guidance will be released on Thursday, April 25, 2024, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s first quarter 2024 financial results and provide a business update.

A live webcast will be available on the Investor Relations section of www.gilead.com and will be archived there for one year.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  215.78
+2.74 (1.29%)
AAPL  263.36
+11.07 (4.39%)
AMD  242.09
+9.01 (3.87%)
BAC  52.20
+0.91 (1.78%)
GOOG  256.82
+3.03 (1.20%)
META  732.84
+15.93 (2.22%)
MSFT  517.94
+4.36 (0.85%)
NVDA  183.60
+0.38 (0.21%)
ORCL  276.86
-14.45 (-4.96%)
TSLA  443.49
+4.18 (0.95%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.